Ceritinib/crizotinibDevelopment of resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1662卷 / 1期

关键词：

D O I：

10.1007/s40278-017-33722-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：92 / 92

相关论文

共 50 条

[21] Ceritinib/crizotinibAcquired resistance and no response: case report
Reactions Weekly, 2022, 1931 (1) : 176 - 176
[22] Ceritinib/crizotinib/lorlatinibDrug resistance: case report
Reactions Weekly, 2018, 1702 (1) : 73 - 73
[23] CrizotinibDevelopment of resistance in advanced stage lung adenocarcinoma : case report
Reactions Weekly, 2017, 1635 (1) : 97 - 97
[24] Alectinib/ceritinib/crizotinibAcquired resistance: case report
Reactions Weekly, 2022, 1901 (1) : 28 - 28
[25] CrizotinibDevelopment of resistance mutation in metastatic adenocarcinoma of the lung: case report
Reactions Weekly, 2016, 1598 (1) : 70 - 70
[26] CrizotinibDevelopment of crizotinib resistance in metastatic lung cancer: case report
Reactions Weekly, 2018, 1683 (1) : 229 - 229
[27] CrizotinibDevelopment of crizotinib resistance leading to disease progression: case report
Reactions Weekly, 2016, 1621 (1) : 83 - 83
[28] CrizotinibDevelopment of crizotinib-resistance in lung adenocarcinoma: case report
Reactions Weekly, 2017, 1635 (1) : 96 - 96
[29] Alectinib/ceritinib/crizotinibAcquired drug resistance: case report
Reactions Weekly, 2021, 1849 (1) : 25 - 25
[30] CrizotinibDevelopment of resistance to crizotinib during treatment of lung cancer: case report
Reactions Weekly, 2018, 1728 (1) : 114 - 114

← 1 2 3 4 5 →